跳至主要内容
临床试验/PACTR202008739887429
PACTR202008739887429Other未知

Role of oxytocin versus tranexamic acid and ethsmyslate in reducing intra operative blood loss in myomectomy

Elgalaa teaching hospital0 个研究点目标入组 180 人开始时间: 2020年8月17日最近更新:

试验速览

阶段
未知
状态
Other
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Year(s) 至 64 Year(s)(—)
性别
Female

入选标准

  • premenopausal patients
  • aged between 30 to 50 years old,
  • five or less symptomatic uterine myomas,
  • maximum diameter of the largest myoma is 6 cm,
  • all myomas are subserous or intramural and uterine size less than 24 weeks pregnancy

排除标准

  • history of previous surgery, hypertension, cardiac and Pulmonary diseases,
  • patients who have bleeding disorders,
  • anemia (Hb< 10g %),
  • chronic endocrine or metabolic diseases such as Diabetes, obesity (body mass index > 30 kg/m²)
  • cases that require intraoperative conversion of myomectomy to hysterectomy

研究者

发起方
Elgalaa teaching hospital

相似试验